Current Applications and Future Perspectives of Photobiomodulation in Ocular Diseases: A Narrative Review
Source abstract
Abstract
The present article provides an overview of photobiomodulation (PBM), also known as low-level laser light therapy (LLLT), which has garnered attention in ophthalmology for its potential therapeutic benefits in various ocular diseases. Photobiomodulation involves the use of low-intensity lasers or light-emitting diodes to stimulate biological processes in target tissues without causing thermal damage. This article discusses how PBM has been explored across various ocular conditions, including ocular surface diseases, age-related macular degeneration, diabetic retinopathy, myopia, amblyopia, and glaucoma. It summarizes findings from human studies and clinical trials demonstrating positive outcomes of PBM treatment in these areas. Moreover, the article emphasizes the importance of establishing standardized treatment protocols in terms of session duration and frequency, light type, and patients’ inclusion criteria to further validate the role of PBM in managing ocular diseases.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Laser Applications in Dentistry and Medicine · Ocular Surface and Contact Lens · Corneal Surgery and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Eye Clinic, Department of Surgical Sciences, University of Cagliari, Via Università 40, 09124 Cagliari, Italy
Department of Ophthalmology, “City of Health and Science” Hospital, University of Turin, Via Chierasco 23, 10126 Turin, Italy
Department of Translational Biomedicine Neuroscience, University of Bari “Aldo Moro”, Piazza Giulio Cesare 11, 70124 Bari, Italy
Eye Clinic, Public Health Department, University of Naples Federico II, Corso Umberto I 40, 80138 Naples, Italy
References (89)
Show source-provided references
1. Noninvasive Red and Near-Infrared Wavelength-Induced Photobiomodulation: Promoting Impaired Cutaneous Wound Healing10.1111/phpp.12282 ↗
2. Effect of Laser Rays on Wound Healing10.1016/0002-9610(71)90482-X ↗
3. Die Wirkung der Lasstrahlen auf den Haarwuchs der Maus [The Effect of Laser Beams on the Growth of Hair in Mice]
4. The NASA Light-Emitting Diode Medical Program-Progress in Space Flight and Terrestrial Applications. Space Technol
5. Mitochondrial Cytochrome c Oxidase Is Not the Primary Acceptor for Near Infrared Light-It Is Mitochondrial Bound Water: The Principles of Low-Level Light Therapy10.21037/atm.2019.01.43 ↗
6. Low-Level Laser Therapy: A Useful Technique for Enhancing the Proliferation of Various Cultured Cells10.1007/s10103-011-0885-2 ↗
7. Light-Emitting Diode Therapy and Low-Level Light Therapy Are Photobiomodulation Therapy
8. Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy
9. Mitochondrial Signaling in Mammalian Cells Activated by Red and Near-IR Radiation10.1111/j.1751-1097.2008.00394.x ↗
10. Photobiomodulation or Low-Level Laser Therapy10.1002/jbio.201670113 ↗
11. Low-Level Laser (Light) Therapy (LLLT) in Skin: Stimulating, Healing, Restoring
12. Hamblin, M.R., Waynant, R.W., and Anders, J. (2009). The Importance of Coherence in Phototherapy, SPIE—The International Society for Optical Engineering.
13. The Importance of Coherency10.1089/pho.2005.23.431 ↗
14. TFOS DEWS II Definition and Classification Report10.1016/j.jtos.2017.05.008 ↗
15. Meibomian Gland Disease: The Role of Gland Dysfunction in Dry Eye Disease10.1016/j.ophtha.2017.05.031 ↗
16. The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Anatomy, Physiology, and Pathophysiology of the Meibomian Gland10.1167/iovs.10-6997c ↗
17. Predicted Phenotypes of Dry Eye: Proposed Consequences of Its Natural History10.1016/S1542-0124(12)70299-9 ↗
18. The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on the Epidemiology of, and Associated Risk Factors for, MGD10.1167/iovs.10-6997e ↗
19. Effect of Low-Level Light Therapy in Patients with Dry Eye: A Prospective, Randomized, Observer-Masked Trial10.1038/s41598-022-07427-6 ↗
20. Low-Level Light Therapy Versus Intense Pulsed Light for the Treatment of Meibomian Gland Dysfunction: Preliminary Results from a Prospective Randomized Comparative Study10.1097/ICO.0000000000002997 ↗
21. Serial Sessions of a Novel Low-Level Light Therapy Device for Home Treatment of Dry Eye Disease10.1007/s40123-022-00619-3 ↗
22. TFOS DEWS II Iatrogenic Report10.1016/j.jtos.2017.05.004 ↗
23. Giannaccare, G., Rossi, C., Borselli, M., Carnovale Scalzo, G., Scalia, G., Pietropaolo, R., Fratto, B., Pellegrini, M., Yu, A.C., and Scorcia, V. (2023). Outcomes of Low-Level Light Therapy Before and After Cataract Surgery for the Prophylaxis of Postoperative Dry Eye: A Prospective Randomised Double-Masked Controlled Clinical Trial. Br. J. Ophthalmol., online ahead of print.10.1136/bjo-2023-323920 ↗
24. Giannaccare, G., Borselli, M., Rossi, C., Carnovale Scalzo, G., Pellegrini, M., Vaccaro, S., Scalia, G., Lionetti, G., Mancini, A., and Bianchi, P. Noninvasive Screening of Ocular Surface Disease in Otherwise Healthy Patients Scheduled for Cataract Surgery. Eur. J. Ophthalmol., 2024. in press.10.1177/11206721241228621 ↗
25. Jordan, G.A., and Beier, K. (2024, January 10). Chalazion, StatPearls [Internet], Available online: https://www.ncbi.nlm.nih.gov/books/NBK499889/.
26. Management of Chalazia in General Practice
27. Chalazions: The Frequency of Spontaneous Resolution10.1136/bmj.287.6405.1595 ↗
28. Huang, J., Guo, M.X., Xiang, D.M., Yan, L.F., Yu, Y., Han, L., Wang, J.X., and Lu, X.H. (2022). The Association of Demodex Infestation with Pediatric Chalazia. BMC Ophthalmol., 22.10.1186/s12886-022-02261-w ↗
29. Low-Level Light Therapy for the Treatment of Recalcitrant Chalazia: A Sample Case Summary10.2147/OPTH.S225506 ↗
30. Age-Related Macular Degeneration: Pathophysiology, Management, and Future Perspectives10.1159/000517520 ↗
31. Age-Related Macular Degeneration10.1016/j.mcna.2021.01.003 ↗
32. Age-Related Eye Disease Study Research Group (2001). The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: The Age-Related Eye Disease Study Report Number 6. Am. J. Ophthalmol., 132, 668–681.10.1016/S0002-9394(01)01218-1 ↗
33. The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration: AREDS Report No. 1710.1001/archopht.123.11.1484 ↗
34. Photobiomodulation Directly Benefits Primary Neurons Functionally Inactivated by Toxins: Role of Cytochrome c Oxidase10.1074/jbc.M409650200 ↗
35. Low Intensity Light Stimulates Nitrite-Dependent Nitric Oxide Synthesis but Not Oxygen Consumption by Cytochrome c Oxidase: Implications for Phototherapy10.1016/j.jphotobiol.2010.12.002 ↗
36. Low-Level Laser Therapy Improves Vision in Patients with Age-Related Macular Degeneration10.1089/pho.2007.2132 ↗
37. Low-Level Nighttime Light Therapy for Age-Related Macular Degeneration: A Randomized Clinical Trial10.1167/iovs.18-24284 ↗
38. Photobiomodulation for non-exudative age-related macular degeneration
39. Photobiomodulation as a New Treatment for Dry Age-Related Macular Degeneration. Results from the Toronto and Oak Ridge Photobimodulation Study in AMD (TORPA)
40. Photobiomodulation Reduces Drusen Volume and Improves Visual Acuity and Contrast Sensitivity in Dry Age-Related Macular Degeneration10.1111/aos.13354 ↗
41. A Double-Masked, Randomized, Sham-Controlled, Single-Center Study with Photobiomodulation for the Treatment of Dry Age-Related Macular Degeneration10.1097/IAE.0000000000002632 ↗
42. Letter to the Editor Regarding “LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration”10.1007/s40123-024-00894-2 ↗
43. LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration10.1007/s40123-022-00640-6 ↗
44. LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the LumiThera Valeda Light Delivery System10.1097/IAE.0000000000003980 ↗
45. Grewal, M.K., Sivapathasuntharam, C., Chandra, S., Gurudas, S., Chong, V., Bird, A., Jeffery, G., and Sivaprasad, S. (2020). A Pilot Study Evaluating the Effects of 670 nm Photobiomodulation in Healthy Ageing and Age-Related Macular Degeneration. J. Clin. Med., 9.10.3390/jcm9041001 ↗
46. Photobiomodulation Therapy for Large Soft Drusen and Drusenoid Pigment Epithelial Detachment in Age-Related Macular Degeneration: A Single-Center Prospective Pilot Study10.1097/IAE.0000000000003805 ↗
47. Parodi, M.B., Antropoli, A., Arrigo, A., Cicinelli, M.V., Bianco, L., Saladino, A., Moretti, E., Bandello, F., and Mansour, A. (2023). Acute Atrophic Evolution of Drusenoid Pigment Epithelium Detachment after Photobiomodulation. Retin. Cases Brief Rep., online ahead of print.10.1097/ICB.0000000000001529 ↗
48. Diabetic Retinopathy10.1038/nrdp.2016.12 ↗
49. Global Prevalence and Major Risk Factors of Diabetic Retinopathy10.2337/dc11-1909 ↗
50. Diabetic Retinopathy: Global Prevalence, Major Risk Factors, Screening Practices and Public Health Challenges: A Review10.1111/ceo.12696 ↗
51. Photobiomodulation in the Treatment of Patients with Non-Center-Involving Diabetic Macular Edema10.1136/bjophthalmol-2013-304477 ↗
52. Preclinical and Clinical Studies of Photobiomodulation Therapy for Macular Edema10.1007/s00125-020-05189-2 ↗
53. A Preliminary Observation on Rod Cell Photobiomodulation in Treating Diabetic Macular Edema
54. Non-Invasive Treatment of Early Diabetic Macular Edema by Multiwavelength Photobiomodulation with the Valeda Light Delivery System10.2147/OPTH.S415883 ↗
55. A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE)10.1016/j.oret.2021.10.003 ↗
56. Causes of Visual Impairment in Children: A Study of 3,210 Cases10.3928/01913913-20070701-04 ↗
57. A Pilot Randomised Clinical Trial of 670 nm Red Light for Reducing Retinopathy of Prematurity10.1038/s41390-019-0520-7 ↗
58. Myopia10.1016/S0140-6736(12)60272-4 ↗
59. The Complications of Myopia: A Review and Meta-Analysis10.1167/iovs.61.4.49 ↗
60. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 205010.1016/j.ophtha.2016.01.006 ↗
61. Lin, Z., Gao, T.Y., Vasudevan, B., Ciuffreda, K.J., Liang, Y.B., Jhanji, V., Fan, S.J., Han, W., and Wang, N.L. (2017). Near Work, Outdoor Activity, and Myopia in Children in Rural China: The Handan Offspring Myopia Study. BMC Ophthalmol., 17.10.1186/s12886-017-0598-9 ↗
62. Myopia Prevalence in Canadian School Children: A Pilot Study10.1038/s41433-018-0015-5 ↗
63. Significance of Outdoor Time for Myopia Prevention: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials10.1159/000501937 ↗
64. Ambient Illuminance, Retinal Dopamine Release and Refractive Development in Chicks10.1016/j.exer.2012.08.004 ↗
65. Effects of Light of Different Spectral Composition on Refractive Development and Retinal Dopamine in Chicks10.1167/iovs.18-23880 ↗
66. A Meta-Analysis of Randomized Controlled Trials Evaluating the Effectiveness and Safety of Repeated Low-Level Red Light Therapy in Slowing the Progression of Myopia in Children and Adolescents10.4103/IJO.IJO_1037_23 ↗
67. Efficacy of Repeated Low-Level Red-Light Therapy for Slowing the Progression of Childhood Myopia: A Systematic Review and Meta-analysis10.1016/j.ajo.2023.03.036 ↗
68. Repeated Low-Level Red Light Therapy for the Control of Myopia in Children: A Meta-Analysis of Randomized Controlled Trials10.1097/ICL.0000000000001020 ↗
69. Effect of Repeated Low-Level Red-Light Therapy for Myopia Control in Children: A Multicenter Randomized Controlled Trial10.1016/j.ophtha.2021.11.023 ↗
70. Longitudinal Changes in Choroidal Structure Following Repeated Low-Level Red-Light Therapy for Myopia Control: Secondary Analysis of a Randomized Controlled Trial10.1097/APO.0000000000000618 ↗
71. Longitudinal Changes and Predictive Value of Choroidal Thickness for Myopia Control after Repeated Low-Level Red-Light Therapy10.1016/j.ophtha.2022.10.002 ↗
72. Sustained and Rebound Effect of Repeated Low-Level Red-Light Therapy on Myopia Control: A 2-Year Post-Trial Follow-Up Study10.1111/ceo.14149 ↗
73. System of Ophthalmology. Vol. VI. Ocular Motility and Strabismus
74. The sensitive period for strabismic amblyopia in humans10.1016/S0161-6420(13)32170-8 ↗
75. Low-level laser therapy improves visual acuity in adolescent and adult patients with amblyopia10.1089/pho.2011.3089 ↗
76. Primary open-angle glaucoma10.1016/S0140-6736(04)16257-0 ↗
77. Variations in primary open-angle glaucoma prevalence by age, gender, and race: A Bayesian meta-analysis10.1167/iovs.06-0299 ↗
78. Surma, M., Anbarasu, K., Dutta, S., Olivera Perez, L.J., Huang, K.C., Meyer, J.S., and Das, A. (2023). Enhanced mitochondrial biogenesis promotes neuroprotection in human pluripotent stem cell-derived retinal ganglion cells. Commun. Biol., 6.10.1038/s42003-023-04576-w ↗
79. Mitochondria as Potential Targets and Initiators of the Blue Light Hazard to the Retina10.1155/2019/6435364 ↗
80. Mitochondria: Their role in ganglion cell death and survival in primary open-angle glaucoma10.1016/j.exer.2010.03.008 ↗
81. Blue Light Action on Mitochondria Leads to Cell Death by Necroptosis10.1007/s11064-016-1946-5 ↗
82. Apoptosis, pyroptosis, and necrosis: Mechanistic description of dead and dying eukaryotic cells10.1128/IAI.73.4.1907-1916.2005 ↗
83. Cell biology: Power games10.1038/443901a ↗
84. Ahn, S.H., Suh, J.S., Lim, G.H., and Kim, T.J. (2023). The Potential Effects of Light Irradiance in Glaucoma and Photobiomodulation Therapy. Bioengineering, 10.10.3390/bioengineering10020223 ↗
85. Near Infrared (NIR) Light Therapy of Eye Diseases: A Review10.7150/ijms.52980 ↗
86. The Beneficial Effects of Photobiomodulation to Reduce Intraocular Pressure in Primary Open-Angle Glaucoma10.9734/or/2023/v18i3387 ↗
87. Photobiomodulation in Light of Our Biological Clock’s Inner Workings10.1089/pho.2018.4445 ↗
88. Yeung, M. (2021). Effect of Photobiomodulation on Mice with Acute Ocular Hypertension. [Master’s Thesis, University of Hong Kong Libraries].
89. Shedding Light on Photobiomodulation Therapy for Age-Related Macular Degeneration: A Narrative Review10.1007/s40123-023-00812-y ↗